Attenuation and Stability of CHIKV-NoLS, a Live-Attenuated Chikungunya Virus Vaccine Candidate
Our previous investigation of the nucleolar localisation sequence (NoLS) of chikungunya virus (CHIKV) capsid protein demonstrated the role of capsid in CHIKV virulence.
Eranga Abeyratne +4 more
doaj +2 more sources
Stability of CHIKV infection models with CHIKV-monocyte and infected-monocyte saturated incidences [PDF]
We study the global stability of within-host Chikungunya virus (CHIKV) infection models with antibodies. We incorporate two modes of infections, attaching a CHIKV to a host monocyte, and contacting an infected monocyte with an uninfected monocyte. The CHIKV-monocyte and infected-monocyte incidence rates are given by saturation.
A. M. Elaiw, S. E. Almalki, A. D. Hobiny
openaire +3 more sources
Infectious Chikungunya Virus (CHIKV) with a Complete Capsid Deletion: a New Approach for a CHIKV Vaccine [PDF]
Currently, there is no licensed vaccine against CHIKV infection. An ideal CHIKV vaccine should generate an optimal balance between efficacy and safety. Live attenuated vaccines that can elicit strong immune responses often involve a trade-off of reduced safety. Here, a novel live attenuated vaccine candidate for CHIKV lacking the entire capsid gene, ΔC-
Ya-Nan Zhang +7 more
openaire +2 more sources
A booster regime of liposome-delivered live-attenuated CHIKV vaccine RNA genome protects against chikungunya virus disease in mice [PDF]
Mosquito-transmitted chikungunya virus (CHIKV) is the causal pathogen of CHIKV disease and is responsible for global epidemics of arthritic disease. CHIKV infection can lead to severe chronic and debilitating arthralgia, significantly impacting patient ...
Abeyratne, E +21 more
core +1 more source
Analysis of Humoral Immune Responses in Chikungunya Virus (CHIKV)-Infected Patients and Individuals Vaccinated With a Candidate CHIKV Vaccine [PDF]
Abstract Background Chikungunya virus (CHIKV) is a mosquito-transmitted alphavirus that causes severe flu-like symptoms. The acute symptoms disappear after 1 week, but chronic arthralgia can persist for years.
Lisa Henss +7 more
openaire +3 more sources
Cutaneous manifestations in six children by CHIKV: a case series
OBJECTIVES: To describe a case series of children diagnosed with Chikungunya virus (CHIKV) infection with atypical dermatologic manifestations, in order to broaden the picture of possibilities for differential diagnoses in cases of similar clinical presentations.
Hellen Moura +7 more
openaire +1 more source
Evaluation of novobiocin and telmisartan for anti-CHIKV activity
Chikungunya has re-emerged as an epidemic with global distribution and high morbidity, necessitating the need for effective therapeutics. We utilized already approved drugs with a good safety profile used in other diseases for their new property of anti-chikungunya activity.
Praveen Kumar, Tripathi +10 more
openaire +2 more sources
Development and Application of Treatment for Chikungunya Fever
Erin M Millsapps, Emma C Underwood, Kelli L Barr Center for Global Health and Infectious Disease Research, University of South Florida, Tampa, FL, USACorrespondence: Kelli L Barr, Center for Global Health and Infectious Disease Research, University of ...
Millsapps EM, Underwood EC, Barr KL
doaj
CHIKV-infected human macrophages show a more robust pro-inflammatory profile.
Cytokine expression in CHIKV-infected human and murine macrophages was quantified by cytometric bead arrays at 24 hpi. Data show mean values of three independent experiments with a total of n = 9, MOI = 5.
E. Shannon Tass (8566689) +4 more
core +1 more source
Preparation and application of chikungunya pseudovirus containing double reporter genes
Chikungunya virus (CHIKV), a highly infectious and rapidly spread viral pathogen, is classified as a pathogenic agent at the biosafety level 3. Operation of live authentic CHIKV needs a specific laboratory with the P3 or above containment, which greatly ...
Chunyan Su +7 more
doaj +1 more source

